Pingting Ye

Shanghai Key Laboratory Of Chemical Assessment And Sustainability
Shanghai, 200120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Oral antibiotics promote triple-negative breast cancer progression by inducing gut microbiota dysbiosis and taurocholic acid accumulation.

Oral antibiotics promote triple-negative breast cancer progression by inducing gut microbiota dysbiosis and taurocholic acid accumulation.

Journal: Acta biochimica et biophysica Sinica

Published: May 13, 2026

Corrigendum to "Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/photodynamic therapy" [Acta Biomaterialia 138, 2022, 463-477].

Corrigendum to "Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/photodynamic therapy" [Acta Biomaterialia 138, 2022, 463-477].

Journal: Acta biomaterialia

Published: July 17, 2025

Correction: Ye et al. The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer. Cancers 2022, 14, 2101.

Correction: Ye et al. The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer. Cancers 2022, 14, 2101.

Journal: Cancers

Published: June 10, 2025

Co-delivery of chemokine CXCL9 and costimulatory ligand TNFSF9 by mesenchymal stem cells reprograms the immune microenvironment for triple-negative breast cancer.

Co-delivery of chemokine CXCL9 and costimulatory ligand TNFSF9 by mesenchymal stem cells reprograms the immune microenvironment for triple-negative breast cancer.

Journal: NPJ breast cancer

Published: April 30, 2025

A responsive cocktail nano-strategy breaking the immune excluded state enhances immunotherapy for triple negative breast cancer.

A responsive cocktail nano-strategy breaking the immune excluded state enhances immunotherapy for triple negative breast cancer.

Journal: Nanoscale

Published: January 15, 2025

Reducing the availability of endogenous copper and glucose for cascade starvation therapy and chemodynamic therapy.

Reducing the availability of endogenous copper and glucose for cascade starvation therapy and chemodynamic therapy.

Journal: Materials today. Bio

Published: January 14, 2025

Dual inhibition of DNA damage repair sensitizes photodynamic therapy for triple negative breast cancer.

Dual inhibition of DNA damage repair sensitizes photodynamic therapy for triple negative breast cancer.

Journal: Materials today. Bio

Published: December 10, 2024

A positive-feedback loop suppresses TNBC tumour growth by remodeling tumour immune microenvironment and inducing ferroptosis.

A positive-feedback loop suppresses TNBC tumour growth by remodeling tumour immune microenvironment and inducing ferroptosis.

Journal: Biomaterials

Published: June 12, 2024

Metformin Ameliorates D-Galactose-Induced Senescent Human Bone Marrow-Derived Mesenchymal Stem Cells by Enhancing Autophagy.

Metformin Ameliorates D-Galactose-Induced Senescent Human Bone Marrow-Derived Mesenchymal Stem Cells by Enhancing Autophagy.

Journal: Stem cells international

Published: November 24, 2022

The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer.

The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer.

Journal: Cancers

Published: February 14, 2022

Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/ photodynamic therapy.

Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/ photodynamic therapy.

Journal: Acta biomaterialia

Published: July 05, 2021

Surgery Plus Chemotherapy Versus Surgery Alone for Limited-Stage Small-Cell Lung Cancer: A Population-Based Survival Outcome Analysis.

Surgery Plus Chemotherapy Versus Surgery Alone for Limited-Stage Small-Cell Lung Cancer: A Population-Based Survival Outcome Analysis.

Journal: Frontiers in oncology

Published: March 05, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026